Biosciences
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E, Bundi C, Kimani D, Nyamako L, Keter K, Mutiso A, Ogwang R, Bellamy D, Rapi K, Bajer A, Provstgaard-Morys S, Stockdale L, Munoz O, Datoo MS, Lawrie A, Ramos-Lopez F, Roberts R, Hamaluba M, Hill AVS, Bejon P, Ewer KJ, Kapulu M
Front Immunol, (2025). 16:1620365
Aflatoxin exposure and mortality in acutely ill children: results from the CHAIN network cohort.Xia L, Wu H, Saleem AF, Mupere E, Lancioni C, Diallo H, Potani I, Ali SA, Voskuijl W, Chisti MJ, Shahid Asmsb Timbwa M, Mwaringa S, Tigoi C, Ngari M, Singa B, Tickell KD, Njunge J, Bandsma R, Ahmed T, Berkley J, Walson JL, Gong Y, Routledge MN
BMJ Glob Health, (2025). 10:
Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).Belij-Rammerstorfer S, Sheehan E, Li G, Bibi S, Wright D, Voysey M, Bissett C, Barman N, Camara S, Yong AA, Costa Clemens SA, Harris M, Flaxman A, Barrett J, Hussain K, Lipunga G, Shaw RH, Smith H, Cheruiyot S, Gitonga JN, Mugo D, Karanja HK, Warimwe GM, Hamaluba MM, Weckx LY, Pollard AJ, Lambe T
EBioMedicine, (2025). 118:105847
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C, Bellamy D, Kibwana E, Nyamako L, Ogwang R, Keter K, Kimani D, Salman AM, Provstgaard-Morys S, Stockdale L, Hill AVS, Bejon P, Olotu A, Hamaluba M, Ewer KJ, Kapulu MC
Front Immunol, (2025). 16:1620366
Toxicity of ivermectin to bed bugs (Cimex hemipterus) and risk factors associated with infestation in Kwale County, coastal Kenya.Odongo T, Omondi I, Wanjiku C, Okoko M, Kiuru C, Kariuki M, Ringera I, Otieno B, Mure F, Furnival-Adams J, Gutierrez AS, Otuko R, Rabinovich NR, Mwangangi J, Chaccour C, Maia MF
Parasit Vectors, (2025). 18:269
Genomic surveillance reveals geographical heterogeneity and differences in known and novel insecticide resistance mechanisms in Anopheles arabiensis across Kenya.Polo B, Bennett KL, Barasa S, Brenas J, Agumba S, Mwangangi J, Wachira L, Kitur S, Matoke-Muhia D, Mburu DM, Ramaita E, Juma EO, Mbogo C, Ochomo E, Clarkson CS, Miles A, Kamau L
BMC Genomics, (2025). 26:599
Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.Musundi S, Mwanga M, Lambisia A, Morobe JM, Murunga N, Moraa E, Ndwiga L, Cheruiyot R, Musyoki J, Mutunga M, Guzman-Rincon LM, Sande C, Mwangangi J, Bejon P, Ochola-Oyier LI, Nokes DJ, Agoti CN, Nyiro J, Githinji G
Virus Evol, (2025). 11:veaf035
Phenotypic and genotypic insecticide resistance profiles of main malaria vectors in Kwale county, coastal Kenya.Okoko M, Karisa J, Gona R, Odongo T, Otieno B, Yaa F, Bartilol B, Meli P, Ondieki Z, Tuwei M, Wanjiku C, Shee F, Chaccour C, Kiuru C, Maia MF
Malar J, (2025). 24:191
The genome sequence of varicella-zoster virus (Varicellovirus humanalpha3) obtained by metagenomics from a patient presenting with an exanthem rash.Musundi S, Okanda D, Lambisia A, Morobe JM, Muthanje E, Ochola-Oyier LI, Carter DP, Agoti CN, Kiiru J, Githinji G
Microbiol Resour Announc, (2025). :e0024825
OSBPL11 is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic health.Mogire RM, Muriuki JM, Bayimenye RF, Mentzer AJ, Chong A, Gouveia MH, Bentley AR, Band G, King'ori P, Mitchell R, Webb EL, Sengupta D, Ekunwe L, Ndungu FM, Morovat A, Macharia AW, Cutland CL, Hemani G, Sirima SB, Ramsay M, Figueiredo CA, Prentice AM, Madhi SA, Raffield LM, Sandhu MS, Bejon P, Smith GD, Elliott AM, Williams TN, Rotimi C, Bourne CR, Burgett A, Adeyemo A, Atkinson SH
medRxiv, (2025). :
Spatial distribution and population structure of the invasive Anopheles stephensi in Kenya from 2022 to 2024.Samake JN, Athinya DK, Milanoi S, Ramaita E, Muchoki M, Omondi S, Abong'o B, Matoke-Muhia D, Mbogo C, Keitany K, Mukabana WR, Oyieke F, Shieshia M, Mburu M, Ogoma S, Nyawira E, Wekesa C, Bartilol B, Rono M, Maia M, O'Meara W, Kahindi S, Rafferty C, Schultz JS, Gutman JR, Gimnig JE, Zohdy S, Ochomo E
Sci Rep, (2025). 15:19878
COVID-19 mortality in Africa and Asia - Authors' reply.Bejon P, Agweyu A, Oyier I, Hamaluba M, Kamuya D, Kinyanjui S, Barasa E
Lancet Infect Dis, (2025). :
An adaptive multiarm randomised trial of biomedical and psychosocial interventions to improve convalescence following severe acute malnutrition in sub-Saharan Africa: Co-SAM trial protocol.Bwakura-Dangarembizi M, Amadi B, Singa BO, Muyemayema S, Ngosa D, Mwalekwa L, Ngao N, Kazhila L, Mutasa B, Mpofu E, Mudawarima L, Gonzales GB, Mudzingwa S, Mutenda M, Keter LK, Mutasa K, Njunge JM, Jones H, Phiri TN, Mudibo E, Chulu N, Majo FD, Chasekwa B, Tembo A, Nyabinda C, Oduol C, Sauramba V, Tavengwa NV, Langhaug L, Cordani I, Smuk M, Jaki T, Ntozini R, Walson J, Tickell KD, Berkley J, Kelly P, Prendergast AJ
BMJ Open, (2025). 15:e093758
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.Chanda C, Kibengo F, Mutua M, Ogada F, Muturi-Kioi V, Akis Yildirim BM, Amondi M, Baines A, Basajja V, Borthwick N, Bosire K, Chambula E, Chetty P, Chinyenze K, Chirro O, Crook A, De Bont J, Fernandez N, Ejou P, Farah B, Glaze M, Gombe B, Gumbe A, Hayes P, Itwi S, Juma S, Kabarambi A, Kabengele C, Kafeero P, Kakande A, Kanungi J, Kidega W, King D, Mahira R, Malogo R, Matsoso M, Michelo C, Moyo A, Mugaba S, Mugenya I, Muhumuza P, Mujadidi YF, Muriuki M, Musale V, Mutua G, Muwowo M, Mwale F, Mwangi I, Nakimbugwe M, Namuyanja A, Nduati E, Nielsen L, Nyange J, Oino G, Okech B, Omosa-Manyonyi G, Otieno D, Palmer S, Phiri H, Ramko K, Rutishauser RL, Sayeed E, Sajabi R, Serwanga J, GTWee E Wenden C, Cicconi P, Fast P, Gilmour J, Jaoko W, Kaleebu P, Kilembe W, Kuipers H, Sanders EJ, Hanke T
Lancet Microbe, (2025). :101041
Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal.Sané R, Sambe BS, Diagne A, Faye J, Sarr FD, Diaw SOM, Sarr I, Diatta AS, Diatta HAM, Sembène PM, Vigan-Womas I, Toure-Balde A, Osier F, Niang M
Sci Rep, (2025). 15:16516
Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes.Ngotho P, Dantzler Press K, Peedell M, Muasya W, Omondi BR, Otoboh SE, Gomez J, Coronado L, Seydel KB, Kapulu M, Laufer M, Taylor T, Bousema T, Marti M
PLoS Pathog, (2025). 21:e1013110
Age structure and parity status determination of Afrotropical malaria vectors using MALDI-TOF MS.Tuwei M, Karisa J, Kiuru C, Ondieki Z, Odongo T, Muturi M, Mure F, Otieno B, Okoko M, Bartilol B, Gona R, Ominde K, Constantino L, Cole G, Anastácio T, Candrinho B, Armazia R, Alves C, Ramaita E, Rono M, Mwangangi J, Mbogo C, Saute F, Chaccour C, Wanjiku C, Maia M
Sci Rep, (2025). 15:15848
Age structure and parity status determination of Afrotropical malaria vectors using MALDI-TOF MS.Tuwei M, Karisa J, Kiuru C, Ondieki Z, Odongo T, Muturi M, Mure F, Otieno B, Okoko M, Bartilol B, Gona R, Ominde K, Constantino L, Cole G, Anastácio T, Candrinho B, Armazia R, Alves C, Ramaita E, Rono M, Mwangangi J, Mbogo C, Saute F, Chaccour C, Wanjiku C, Maia M
Sci Rep, (2025). 15:15848
Stable Plasmodium falciparum merozoite surface protein-1 allelic diversity despite decreasing parasitaemia in children with multiple malaria infections.Yaa RM, Kimenyi KM, Palasciano HA, Obiero G, Ochola-Oyier LI
Malar J, (2025). 24:136
Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella.Randall AZ, Conti V, Nakakana U, Liang X, Teng AA, Di Pasquale AL, Kapulu M, Frenck RJr, Launay O, Ferruzzi P, Sciré AS, Marchetti E, Obiero C, Pablo JV, Edgar J, Bejon P, Shandling AD, Campo JJ, Yee A, Martin LB, Podda A, Micoli F
mSphere, (2025). :e0105724
